April 25, 2018
An Arizona startup is hoping its unique compounds will lead to treatments to halt or slow the progression of a devastating neurodegenerative disease that affects nearly 6 million Americans. Iluminos Therapeutics has licensed compounds created at the University of Arizona that have the potential to treat neurodegenerative disease, in particular […]
